These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1431 related articles for article (PubMed ID: 28625832)

  • 1. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
    Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
    Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
    Cox SR; Lindsay JO; Fromentin S; Stagg AJ; McCarthy NE; Galleron N; Ibraim SB; Roume H; Levenez F; Pons N; Maziers N; Lomer MC; Ehrlich SD; Irving PM; Whelan K
    Gastroenterology; 2020 Jan; 158(1):176-188.e7. PubMed ID: 31586453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria.
    Wilson B; Rossi M; Kanno T; Parkes GC; Anderson S; Mason AJ; Irving PM; Lomer MC; Whelan K
    Am J Gastroenterol; 2020 Jun; 115(6):906-915. PubMed ID: 32433273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics.
    Staudacher HM; Scholz M; Lomer MC; Ralph FS; Irving PM; Lindsay JO; Fava F; Tuohy K; Whelan K
    Clin Nutr; 2021 Apr; 40(4):1861-1870. PubMed ID: 33183883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs.
    Harvie RM; Chisholm AW; Bisanz JE; Burton JP; Herbison P; Schultz K; Schultz M
    World J Gastroenterol; 2017 Jul; 23(25):4632-4643. PubMed ID: 28740352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.
    Bennet SMP; Böhn L; Störsrud S; Liljebo T; Collin L; Lindfors P; Törnblom H; Öhman L; Simrén M
    Gut; 2018 May; 67(5):872-881. PubMed ID: 28416515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D.
    Eswaran SL; Chey WD; Han-Markey T; Ball S; Jackson K
    Am J Gastroenterol; 2016 Dec; 111(12):1824-1832. PubMed ID: 27725652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
    Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
    Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.
    Zahedi MJ; Behrouz V; Azimi M
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1192-1199. PubMed ID: 29159993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome.
    Van den Houte K; Colomier E; Routhiaux K; Mariën Z; Schol J; Van den Bergh J; Vanderstappen J; Pauwels N; Joos A; Arts J; Caenepeel P; De Clerck F; Matthys C; Meulemans A; Jones M; Vanuytsel T; Carbone F; Tack J
    Gastroenterology; 2024 Jul; 167(2):333-342. PubMed ID: 38401741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.
    Maagaard L; Ankersen DV; Végh Z; Burisch J; Jensen L; Pedersen N; Munkholm P
    World J Gastroenterol; 2016 Apr; 22(15):4009-19. PubMed ID: 27099444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome.
    Rossi M; Aggio R; Staudacher HM; Lomer MC; Lindsay JO; Irving P; Probert C; Whelan K
    Clin Gastroenterol Hepatol; 2018 Mar; 16(3):385-391.e1. PubMed ID: 28993261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome.
    Hustoft TN; Hausken T; Ystad SO; Valeur J; Brokstad K; Hatlebakk JG; Lied GA
    Neurogastroenterol Motil; 2017 Apr; 29(4):. PubMed ID: 27747984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A low FODMAP diet plus traditional dietary advice versus a low-carbohydrate diet versus pharmacological treatment in irritable bowel syndrome (CARIBS): a single-centre, single-blind, randomised controlled trial.
    Nybacka S; Törnblom H; Josefsson A; Hreinsson JP; Böhn L; Frändemark Å; Weznaver C; Störsrud S; Simrén M
    Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):507-520. PubMed ID: 38643782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.
    Pedersen N; Andersen NN; Végh Z; Jensen L; Ankersen DV; Felding M; Simonsen MH; Burisch J; Munkholm P
    World J Gastroenterol; 2014 Nov; 20(43):16215-26. PubMed ID: 25473176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis.
    Altobelli E; Del Negro V; Angeletti PM; Latella G
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28846594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial.
    Ankersen DV; Weimers P; Bennedsen M; Haaber AB; Fjordside EL; Beber ME; Lieven C; Saboori S; Vad N; Rannem T; Marker D; Paridaens K; Frahm S; Jensen L; Rosager Hansen M; Burisch J; Munkholm P
    J Med Internet Res; 2021 Dec; 23(12):e30291. PubMed ID: 34904950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management?
    Abhari K; Saadati S; Hosseini-Oskouiee F; Yari Z; Hosseini H; Sohrab G; Hejazi E; Agah S; Sadeghi A; Hekmatdoost A
    Eur J Nutr; 2020 Aug; 59(5):2111-2117. PubMed ID: 31327047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.
    McIntosh K; Reed DE; Schneider T; Dang F; Keshteli AH; De Palma G; Madsen K; Bercik P; Vanner S
    Gut; 2017 Jul; 66(7):1241-1251. PubMed ID: 26976734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.